CoChat

Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders

Dhansay, Y, Ipser, JC, Stein, DJ · 2005 · Cochrane Database of Systematic Reviews
Cited by 48

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: 1) To identify and review all randomised controlled trials (RCTs) of pharmacotherapy augmentation of treatment‐resistant/refractory anxiety disorders 2) To estimate the efficacy of pharmacotherapy augmentation strategies for each treatment‐resistant/refractory anxiety disorder 3) To identify which factors (clinical, methodological) predict response to pharmacotherapy

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd005473

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 28

  1. Ackerman, 2002, Multivariate meta-analysis of controlled drug studies for obsessive-compulsive disorder, Journal of Clinical Psychopharmacology, 22, 309, 10.1097/00004714-200206000-00012 · DOI · Paper page
  2. Alderson, 2004, Assessment of study quality
  3. 1994, Diagnostic and statistical manual of mental disorders (DSM-IV)
  4. Ballenger, 1998, International Consensus group on Depression and Anxiety, Journal of Clinical Psychiatry, 59 Suppl 8, 47
  5. Bandelow, 2002, World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders, World Journal of Biological Psychiatry, 3, 171, 10.3109/15622970209150621 · DOI · Paper page
  6. Barlow DH, 2001, Clinical handbook of psychological disorders: A step-by-step treatment manual (3rd Ed.)
  7. Berlin, 1999, Measuring the quality of trials: The quality of quality scales, JAMA, 282, 1083, 10.1001/jama.282.11.1083 · DOI
  8. Blake, 1990, A clinician rating scale for assessing current and lifetime PTSD: The CAPS-1, Behavior Therapy, 21, 187
  9. Blanco, 2003, The evidence-based pharmacological treatment of social anxiety disorder, International Journal of Neuropsychopharmacology, 6, 427, 10.1017/S1461145703003791 · DOI
  10. Boyer, 1995, Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: A meta-analysis, Psychopharmacology, 10, 45
  11. Copas, 2001, A sensitivity analysis for publication bias in systematic reviews, Statistical Methods in Medical Research, 10, 251, 10.1177/096228020101000402 · DOI · Paper page
  12. Davidson, 1998, Treatment of posttraumatic stress disorder with nefazodone, International Clinical Psychopharmacology, 13, 111, 10.1097/00004850-199805000-00003 · DOI
  13. Deeks, 2003, Cochrane Reviewers’ Handbook 4.2.1 [updated December 2003]
  14. Goodman, 1989, The Yale-Brown Obsessive Compulsive Scale: I. Development, use, and reliability, Archives of General Psychiatry, 46, 1006, 10.1001/archpsyc.1989.01810110048007 · DOI · Paper page
  15. Gury, 1999, Pharmacokinetics of SSRI antidepressants: half-life and clinical applicability, Encephale, 25, 470
  16. Guy, 1976, ECDEU assessment manual for psychopharmacology
  17. Hamilton, 1959, The assessment of anxiety states by rating, British Journal of Medical Psychology, 32, 50, 10.1111/j.2044-8341.1959.tb00467.x · DOI · Paper page
  18. Hamilton, 1960, A rating scale for depression, Journal of Neurology, Neurosurgery & Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 · DOI · Paper page
  19. Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 · DOI · Paper page
  20. Karno, 1988, The epidemiology of obsessive-compulsive disorder in five US communities, Archives of General Psychiatry, 45, 1094, 10.1001/archpsyc.1988.01800360042006 · DOI · Paper page
  21. Kessler, 1994, Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey, Archives of General Psychiatry, 51, 8, 10.1001/archpsyc.1994.03950010008002 · DOI · Paper page
  22. McDougle, 1994, Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics, Archives of General Psychiatry, 51, 302, 10.1001/archpsyc.1994.03950040046006 · DOI · Paper page
  23. Montgomery, 1999, Obsessive-Compulsive Disorder: A practical guide
  24. Murray, 1994, The global burden of disease in 1990: summary results, sensitivity analysis and future directions, Bulletine of the World Health Organisation, 72, 495
  25. Shear, 1992, Panic Disorder Severity Scale (PDSS)
  26. Spitzer, 1996, Instructional manual for the structured clinical interview for DSM-IV
  27. Stein, 2000, Pharmacotherapt for posttraumatic stress disorder, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD002795 · DOI
  28. Stein, 2002, Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study, American Journal of Psychiatry, 159, 1777, 10.1176/appi.ajp.159.10.1777 · DOI · Paper page

Cited by

See all 48

Metadata

Authors
Dhansay, Y., Ipser, J., & Stein, D.
Venue
Cochrane Database of Systematic Reviews
Published
2005-07-20
ISSN
1361-6137 (ISSN-L)
OpenAlex
W4256182809
Cited by
48
References
13
Type
reference entry
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.